Standout Papers

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early c... 2001 2026 2009 2017 604
  1. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials (2001)
    J I Johnson, Shannon Decker et al. British Journal of Cancer

Immediate Impact

10 by Nobel laureates 28 from Science/Nature 70 standout
Sub-graph 1 of 21

Citing Papers

Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
2019 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
1 intermediate paper

Works of Daniel Zaharevitz being referenced

A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-Based Approach
2005
Paullones, a Series of Cyclin-Dependent Kinase Inhibitors:  Synthesis, Evaluation of CDK1/Cyclin B Inhibition, and in Vitro Antitumor Activity
1999
and 1 more

Author Peers

Author Last Decade Papers Cites
Daniel Zaharevitz 2153 1172 1093 51 3.9k
Rick Gussio 1857 905 1115 68 3.5k
Ian R. Hardcastle 1785 988 1097 81 3.1k
Andreas Vogt 3013 998 740 111 4.6k
James E. Strickler 3421 1039 793 46 6.0k
Christoph Schächtele 2399 617 971 77 4.2k
Laura Sepp‐Lorenzino 3507 1027 729 78 4.8k
Sophie Leclerc 2248 1266 1054 18 3.7k
Stefania Sarno 3635 894 549 79 4.8k
Kieran F. Geoghegan 3227 736 640 88 5.6k
E. Schönbrunn 3694 723 582 96 5.3k

All Works

Loading papers...

Rankless by CCL
2026